|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02196 FOSUN PHARMA
Nominal 
18.400 +0.080 (+0.437%) | 2023/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Turnover | 21,315,899 | 0.194% | 43,811,385 | 38,864,174 | 30,163,260 | 28,389,277 | |
| Cost of Sales | (10,698,520) | -7.577% | (23,169,690) | (20,229,785) | (13,733,529) | (11,543,421) | |
| Gross Profit | 10,617,379 | 9.469% | 20,641,695 | 18,634,389 | 16,429,731 | 16,845,856 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (57,976) | 153.613% | (65,369) | (74,016) | (104,836) | (97,114) | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | 1,022,263 | 27.940% | 1,835,146 | 1,789,137 | 1,580,335 | 1,431,414 | |
| Profit / (Loss) before Taxation | 2,661,640 | 11.900% | 4,580,552 | 6,042,670 | 4,677,846 | 4,525,753 | |
| Taxation | (610,245) | 19.871% | (626,918) | (1,066,401) | (737,865) | (782,231) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (267,753) | -15.266% | (216,659) | (247,558) | (277,168) | (421,904) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,783,642 | 14.814% | 3,736,975 | 4,728,711 | 3,662,813 | 3,321,618 | |
| Net Finance Costs / (Income) | 431,881 | 35.059% | 681,172 | 588,755 | 681,343 | 888,042 | |
| Depreciation & Amortisation | 1,565,006 | 47.042% | 2,447,605 | 1,948,448 | 1,728,137 | 1,520,479 | |
| Directors' Emoluments | -- | -- | -- | 39,627 | 31,033 | 26,864 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 67.000 | -- | 143.000 | 185.000 | 143.000 | 130.000 |
| DPS (cts) | 0.000 | -- | 42.000 | 56.000 | 43.000 | 39.000 |
| Dividend Payout Ratio (%) | -- | -- | 29.371% | 30.270% | 30.070% | 30.000% |
| Cash flow per share ($) | -- | -- | -- | -- | 1.007 | 1.257 |
| NBV per share ($) | 16.996 | -- | 16.665 | 15.271 | 14.413 | 12.420 |
| Remarks: | Real time quote last updated: 29/09/2023 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,783,642 |
| %Change | 14.814% |
| EPS / (LPS) | RMB 0.670 |
| NBV Per Share (¥) | RMB 16.996 |